Tony Fitzgerald

Tony Fitzgerald began their work experience in 2015 as the Co-Founder and CEO of Alerte Digital Health, where they served until 2019. In 2014, they founded and directed Selvax Pty Ltd, a company focused on developing a novel cancer immunotherapy. Currently, since 2020, they hold the role of MD & Co-Founder at Avicena Systems, a company specializing in designing and manufacturing ultra-high throughput molecular assay instruments.

Tony Fitzgerald attended the University of Western Australia and California State University Fullerton from 1973 to 1981. During this period, they achieved a Master's Degree and Bachelor's Degrees in Arts, Jurisprudence, and Law. Tony'sfield of study revolved around Law and Public Finance.